To MONITOR TREATMENT OF a LARGE COHORT OF PATIENTS WITH Β-Thalassaemia MAJOR, INTERMEDIA & SICKLE CELL ANAEMIA IN ORDER TO ESTABLISH THE RESPONSE TO TRANS-RESVERATROL AND THE ASSOCIATED ELEMENTS.

International Journal of Advanced Research
doi 10.21474/ijar01/4827
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Journal Of Advanced Research

Related search

Α-Haemoglobin Pool Measurement: A Useful Biomarker for Evaluation of Β-Thalassaemia Intermedia? - Response to Huang and Li

British Journal of Haematology
Hematology
2017English

Treatment of Sickle-Cell Anaemia

BMJ
1963English

Indices of Iron Status Are Nearer to Normal Levels in Foetal Haemoglobin Persistent Sickle Cell Anaemia Compared to the Sickle Cell Anaemia With Low Foetal Haemoglobin

The Journal of Medical Research
2017English

Frequency of Sickle Cell Anaemia and Sickle Cell Trait in Patients Referred to Heglig Hospital in Western Kordofan State (Sudan)

Journal of Evolution of Medical and Dental Sciences
2018English

Liver Enzymes and Trace Elements in the Acute Phase of Sickle Cell Anaemia

West African Journal of Medicine
2011English

Coinheritance of Β-Thalassemia and Sickle Cell Anaemia in Southwestern Nigeria

Ethiopian journal of health sciences
Medicine
2016English

The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients With Major Depressive Disorder?

Neuropsychiatry
PsychiatryMental HealthNeurology
2017English

Hepatopulmonary Syndrome Associated With Iron Overload in Sickle Cell Anaemia

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

PO-0161 Treatment of Iron Overload With Deferasirox in the Patients With Thalassaemia Major

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy